ReviewClinical rheumatology2021

Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature.

Francisco Airton Castro Rocha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.